Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation CARD6_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-22003 | CARD6 | up-regulates | TEAD4 | activates | R-3367 | 6 | 1 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-22006 | CARD6 | down-regulates | NKX6-1 | represses | R-2843 | 20 | 2 | Drugs (2) |
CMF-40402 | CARD6 | down-regulates | hsa-mir-340 | represses | R-2395 | 40 | 3 | Drugs (16) Regulator Drugs (0)Regulon Drugs (16)PONEZUMAB, CRENEZUMAB, ELIGLUSTAT, GANTENERUMAB, SOLANEZUMAB, ELIGLUSTAT TARTRATE, MIGLUSTAT, BAPINEUZUMAB, GSK933776, SATRALIZUMAB, LUCERASTAT, ADUCANUMAB, TRAMIPROSATE, LECANEMAB, DONANEMAB, VANUTIDE CRIDIFICAR |
CMF-40403 | CARD6 | down-regulates | hsa-mir-340 | represses | R-2760 | 40 | 3 | Drugs (3) |
CMF-40404 | CARD6 | down-regulates | hsa-mir-340 | represses | R-1510 | 40 | 3 | Drugs (16) Regulator Drugs (0)Regulon Drugs (16)PONEZUMAB, CRENEZUMAB, ELIGLUSTAT, GANTENERUMAB, SOLANEZUMAB, ELIGLUSTAT TARTRATE, MIGLUSTAT, BAPINEUZUMAB, GSK933776, SATRALIZUMAB, LUCERASTAT, ADUCANUMAB, TRAMIPROSATE, LECANEMAB, DONANEMAB, VANUTIDE CRIDIFICAR |